Biopeptides with antioxidant and anti-inflammatory potential in the prevention and treatment of diabesity disease

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 816-826

  Martínez Leo, Edwin Enrique ^a   Acevedo Fernández, Juan José ^b   Segura Campos, Maira Rubi ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Biopeptides; Diabesity disease; Inflammation; Oxidative stress

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; BIOPEPTIDE; FREE RADICAL; UNCLASSIFIED DRUG; PEPTIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; CHRONIC INFLAMMATION; DIABESITY; DIABETES MELLITUS; DRUG MECHANISM; DRUG POTENCY; HUMAN; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; DRUG EFFECTS;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIABETES MELLITUS; HUMANS; OBESITY; OXIDATIVE STRESS; PEPTIDES;

EID: 84982712462     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.07.051     Document Type: Review

References (120)

1. [1] WHO, Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894, 2012, Organización Mundial de la Salud, Ginebra.
2. [2] Glassman, A., Gaziano, T.A., Buendia, C.P.B., Guanais, F., Confronting the chronic disease burden in Latin America and the Caribbean. Health Affair 29 (2010), 2142–2148.
3. [3] Jones, D., Chronic disease in the twentieth century: a history. GPHS 10 (2015), 414–415.
4. [4] Huang, C.J., McAllister, M., Slusher, A., Webb, H., Mock, J., Acevedo, E., Obesity-Related oxidative stress: the impact of physical activity and diet manipulation. Sports Med. 1 (2015), 1–12.
5. [5] Duchrow, T., Shtatland, T., Guettler, D., Pivovarov, M., Kramer, S., Weissleder, R., Enhancing navigation in biomedical databases by community voting and database-driven text classification. BMC Bioinf. 10 (2009), 1–15.
6. [6] Minkiewicz, P., Dziuba, J., Iwaniak, A., Dziuba, M., Darewicz, M., BIOPEP database and other programs for processing bioactive peptide sequences. J. AOAC Int. 91 (2008), 965–980.
7. [7] Desiere, F., Deutsch, E., King, N., Nesvizhskii, A., Mallick, P., Eng, J., et al. The PeptideAtlas project. Nucleic Acids Res. 34 (2006), D655–D658.
8. [8] Niua, Y., DesMarais, T., Tong, Z., Yao, Y., Costa, M., Oxidative stress alters global histone modification and DNA methylation. Free Radic. Biol. Med. 82 (2015), 22–28.
9. [9] Zuo, Y., Xiang, B., Yang, J., Sun, X., Wang, Y., Cang, H., Yi, J., Oxidative modification of caspase-9 facilitates its activation via disulfide-mediated interaction with Apaf-1. Cell Res. 19 (2009), 449–457.
10. [11] Filomeni, G., De Zio, D., Cecconi, F., Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 22 (2015), 377–388.
11. [12] Halliwell, B., Free radicals and antioxidants. Trends Pharmacol. Sci. 32 (2011), 125–130.
12. [13] Vaziri, N., Lin, C., Farmand, F., Sindhu, R., Superoxide dismutase catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. Kidney Int. 63 (2003), 186–194.
13. [14] Kang, M., Kim, H., Piao, C., Lee, K., Hyun, J., The critical role of catalase in prooxidant and antioxidant function of p53. Cell Death Differ. 20 (2013), 117–129.
14. [15] Förstermann, U., Oxidative stress in vascular disease: causes: defense mechanisms and potential therapies. Nat. Rev. Cardiol. 5 (2008), 338–349.
15. [16] Vincent, H.K., Taylor, A.G., Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int. J. Obesity 30 (2006), 400–418.
16. [17] Johnson, A.R., Milner, J.J., Makowski, L., The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 249 (2012), 218–238.
17. [18] Montgomery, S.L., Bowers, W.J., Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 7 (2012), 42–59.
18. [19] Rotter, V., Nagaev, I., Smith, U., Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278 (2003), 45777–45784.
19. [20] Solini, A., Muscelli, E., Stignani, M., Melchiorri, L., Santini, E., Rossi, C., et al. Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity. J. Clin. Endocr. Metab. 95 (2010), 3342–3346.
20. [21] Wensveen, F., Jelenčić, V., Valentić, S., Šestan, M., Wensveen, T., Theurich, S., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 16 (2015), 376–385.
21. [22] Olusi, S.O., Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int. J. Obesity Rel. Metab. Disor. 26 (2002), 1159–1164.
22. [23] Myara, I., Alamowitch, C., Michel, O., Heudes, D., Bariety, J., Guy-Grand, B., et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes. Res. 11 (2003), 112–120.
23. [24] Skrha, J., Sindelka, G., Kvasnicka, J., Hilgertova, J., Insulin action and fibrinolysis influenced by vitamin E in obese type 2 diabetes mellitus. Diabetes Res. Clin. Pr. 44 (2009), 27–33.
24. [25] Davi, G., Guagnano, M.T., Ciabattoni, G., Basili, S., Falco, A., et al. Platelet activation in obese women: role of inflammation and oxidant stress. J. Am. Med. Assoc. 288 (2002), 2008–2014.
25. [26] Cao, H., Adipocytokines in obesity and metabolic disease. J. Endocrinol. 220 (2014), T47–T59.
26. [27] Nakanishi, S., Yamane, K., Ohishi, W., Nakashima, R., Yoneda, M., Nojima, H., et al. Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res. Clin. Pract. 81 (2008), 381–385.
27. [28] Agrawal, N.K., Kant, S., Targeting inflammation in diabetes: newer therapeutic options. World J. Diabetes 5 (2014), 697–710.
28. [29] Niewczas, M., Gohda, T., Skupien, J., Los receptores circulantes 1 y 2 de TNF ¿pueden predecir el desarrollo de enfermedad renal terminal en la diabetes mellitus tipo 2?. Nefrol clin. 23 (2012), 507–515.
29. [30] Kofler, S., Nickel, T., Weis, M., Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci. 108 (2005), 205–213.
30. [31] Gasca, M., Galeano, J., Relación entre las concentraciones de citocinas factor de necrosis tumoral-alfa, interleucina 6 (TNF-α, IL-6) y la proteína c reactiva (PCR) en pacientes con síndrome metabólico. Inflammation 23 (2009), 9–21.
31. [32] Rosen, P., Nawroth, P.P., King, G., Moller, W., Tritschler, H.J., et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17 (2001), 189–212.
32. [33] Giacco, F., Brownlee, M., Oxidative stress and diabetic complications. Circ. Res. 107 (2010), 1058–1070.
33. [34] Haro, M.I., Esparza, R., Delgado, J.U., Ayala, R.I., Ultra-sensitive C reactive protein associated to nutritional status and biochemical profile in Mexican school children. Rev. Med. Inst. Mex. Seguro Soc. 52 (2014), 398–403.
34. [35] Ames, B.N., Cathcart, R., Schwiers, E., Hochstein, P., Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U. S. A. 78 (1981), 6858–6862.
35. [36] Vítek, L., Novotný, L., Žák, A., Staňková, B., Zima, T., et al. Relationship between serum bilirubin and uric acid to oxidative stress markers in Italian and Czech populations. J. Appl. Biomed. 11 (2013), 209–221.
36. [37] Vítek, L., The role of bilirubin in diabetes metabolic syndrome, and cardiovascular diseases. Front. Pharmacol. 3 (2012), 55–60.
37. [38] Dong, H., Huang, H., Yun, X., Kim, D.S., Yue, Y., et al. Bilirubin increases insulin sensitivity in leptin- receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation. Endocrinol 155 (2014), 818–828.
38. [39] Salazar, R., Barahona, A., Hilda, H., Oleas, M., Bermeo, B., Marcadores de estrés oxidativo y su relación con el estado nutricional en adultos. Ecuador. Arch. Latinoam. Nutr. 64 (2014), 264–270.
39. [40] Bravo, A., Araujo, S., Vargas, M., Mesa, J., Souki, A., et al. Actividad de la enzima antioxidante superóxido dismutasa y niveles de cobre y zinc en pacientes con diabetes mellitus tipo 2. Arch. Venezo Farm. 26 (2007), 37–41.
40. [41] Montano, M., Barrio, L., Gottlieb, M., Schwanke, Ch., Da Rocha, M., et al. Association between manganese superoxide dismutase (SOD2) gene polymorphism and elderly obesity. Mol. Cell. Biochem. 328 (2009), 33–40.
41. [42] Meertens, L., Ruido, T., Díaz, N., Naddaf, G., Rodríguez, A., Solano, L., Relación entre lípidos séricos y estado de las vitaminas C y E como antioxidantes en adultos mayores venezolanos. Arch. Latinoam. Nutr. 58 (2008), 363–370.
42. [43] Day, B., Antioxidant therapeutics: pandora's box. Free Radic. Biol. Med. 8 (2014), 58–64.
43. [44] Nakamura, Y., Omaye, S., Vitamin E-modulated gene expression associated with ROS generation. J. Funct. Foods 1 (2009), 241–252.
44. [45] Jiang, Q., Natural forms of vitamin E: metabolism antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic. Biol. Med. 72 (2014), 76–90.
45. [46] Shargorodsky, M., Debby, O., Matas, Z., Zimlichman, R., Effect of long-term treatment with antioxidants (vitamin C vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr. Metab. 7 (2010), 1–8.
46. [47] Xiao, J., Dietary polyphenols and diabetes: understanding their mechanism of action. Free Radic. Biol. Med. 76 (2014), S96–S97.
47. [48] Muchová, J., Országhová, Z., Žitnanová, I., Trebatický, B., Breza, J., et al. P63- The effect of natural polyphenols on the oxidative stress markers in patients with diabetic nephropathy. Free Radic. Biol. Med. 75 (2014), S42–S48.
48. [49] Herrera, F., Betancur, D., Segura, M., Compuestos bioactivos de la dieta con potencial en la prevención de patologías relacionadas con sobrepeso y obesidad: péptidos biológicamente activos. Nutr. Hosp. 29 (2014), 10–20.
49. [50] Thomas, P.R., Eart, R., Enhancing the food supply. Nutr. Food Sci. 6 (1994), 98–142.
50. [51] Xu, Y., Perspectives on the 21st century development of functional foods: bringing Chinese medicatet diet and functional foods. Int. J. Food Sci. Technol. 36 (2001), 229–242.
51. [52] Segura, M., Chel, L., Betancur, D., Péptidos bioactivos como promotores de la salud. Industria Alimentaria 31 (2009), 10–15.
52. [53] Segura, M., Chel, L., Betancur, D., Bioactividad de péptidos derivados de proteínas alimentarias. 2013, OmniaScience, Barcelona.
53. [54] Korhonen, H., Milk-derived bioactive peptides: from science to applications. J. Funct. Foods 1 (2009), 177–187.
54. [55] Jäkälä, P., Jauhiainen, T., Korpela, R., Vapaatalo, H., Milk protein-derived bioactive tripeptides Ile-Pro–Pro and Val-Pro–Pro protect endothelial function in vitro in hypertensive rats. J. Funct. Foods 1 (2009), 266–273.
55. [56] Shi, J., Ahlroos-Lehmus, A., Pilvi, T., Kekkonen, R., Korpela, R., Mervaala, E., Comparison of the metabolic effects of milk-derived α-lactalbumin and amino acids mixture with equal composition in diet-induced obese mice. J. Funct. Foods 3 (2011), 70–78.
56. [57] Kim, S., Wijesekara, I., Development and biological activities of marine-derived bioactive peptides: a review. J. Funct. Foods 2 (2010), 1–9.
57. [58] Harnedy, P., FitzGerald, R., Bioactive peptides from marine processing waste and shellfish: a review. J. Funct. Foods 4 (2012), 6–24.
58. [59] Samaranayaka, A., Li-Chan, E., Food derived peptidic antioxidants: a review of their production assessment, and potential aplications. J. Funct. Foods 3 (2011), 229–254.
59. [60] Vioque, J., Pedroche, J., Yust, M., Lari, M., Megías, C., et al. Bioactive peptides in storage plants proteins. Braz. J. Food Technol., 2006, 99–102.
60. [61] Sarmadi, B., Ismail, A., Antioxidative peptides from food proteins: a review. Peptides 31 (2010), 1949–1956.
61. [62] Rodney, L., Mosoni, L., Barbara, S.B., Earl, R.S., Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 15036–15040.
62. [63] Chen, H., Koji, M., Fumio, Y., Kenshiro, F., Kiyoshi, N., Antioxidative properties of Histidine-containing peptides designed from peptide fragments found in the digests of a Soybean protein. J. Agric. Food Chem. 46 (1998), 49–53.
63. [64] Kunio, S., Chen, J., Isolation and characterization of peptides with Antioxidant activity derived from Wheat Gluten. Food Sci. Technol. Res. 8 (2002), 227–230.
64. [65] Saito, K., Hao, J., Ogawa, T., Muramoto, K., Hatakeyama, E., Yasuhara, T., et al. Antioxidative properties of tripeptide libraries prepared by combinatorial chemistry. J. Agric. Food Chem. 51 (2003), 3668–3674.
65. [66] Chen, H., Muramoto, K., Yamauchi, F., Structural analysis of antioxidative peptides from soybean α-conglicinina. J. Agric. Food Chem. 43 (1995), 574–578.
66. [67] Gallegos, S., Chel, L., Corzo, L., Martínez, L., Péptidos con actividad antioxidante de proteínas vegetales. En Segura, M., Chel, L., Betancur, D., (eds.) Bioactividad de péptidos derivados de proteínas alimentarias, 2013, OmniaScience, Barcelona, 111–122.
67. [68] Kudo, K., Onodera, S., Takeda, Y., Benkeblia, N., Shiomi, N., Antioxidative activities of some peptides isolated from hydrolyzed potato protein extract. J. Funct. Foods 1 (2009), 170–176.
68. [69] Zhao, K., Zhao, G., Wu, D., Soong, Y., Birk, A.V., et al. Cell permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death and reperfusion injury. J. Biol. Chem. 279 (2004), 34682–34690.
69. [70] Korhonen, H., Pihlanto, A., Review: bioactive peptides: production and functionality. Int Dairy J. 16 (2006), 945–960.
70. [71] Sun, L., Zhang, Y., Zhuang, Y., Antiphotoaging effect and purification of an antioxidant peptide from tilapia (Oreochromis niloticus) gelatin peptides. J. Funct. Foods 5 (2013), 154–162.
71. [72] Wiriyaphan, C., Chitsomboon, B., Roytrakul, S., Yongsawadigu, J., Isolation and identification of antioxidative peptides from hydrolysate of threadfin bream surimi processing by product. J. Funct. Foods. 5 (2013), 1654–1664.
72. [73] Chang, S., Ismail, A., Yanagita, T., Esa, N., Baharuldin, M., Antioxidant peptides purified and identified from the oil palm (Elaeis guineensis Jacq) kernel protein hydrolysate. J. Funct. Foods 14 (2015), 63–75.
73. [74] Zhang, M., Mu, T., Sun, M., Purification and identification of antioxidant peptides from sweet potato protein hydrolysates by Alcalase. J. Funct. Foods 7 (2014), 191–200.
74. [75] Memarpoor-Yazdi, M., Asoodeh, A., Chamani, J., A novel antioxidant and antimicrobial peptide from hen egg white lysozyme hydrolysates. J. Funct. Foods 4 (2012), 278–286.
75. [76] Zhuang, H., Tang, N., Yuan, Y., Purification and identification of antioxidant peptides from corn gluten meal. J. Funct. Food. 5 (2013), 1810–1821.
76. [77] Herrera, F., Ruiz, J., Acevedo, J., Betancur, D., Segura, M., ACE inhibitory, hypotensive and antioxidant peptide fractions from Mucuna pruriens proteins. Process Biochem., 2014, 1–8.
77. [78] Wu, Y., Tian, Q., Li, L., Khan, M., Yang, X., Zhang, Z., et al. Inhibitory effect of antioxidant peptides derived from Pinctada fucata protein on ultraviolet-induced photoaging in mice. J. Funct. Foods 5 (2013), 527–538.
78. [79] Garcés-Rimón, M., González, C., Uranga, J.A., López-Miranda, V., López-Fandiño, R., Miguel, M., Pepsin EggWhite hydrolysate ameliorates obesity-Related oxidative stress: inflammation and steatosis in zucker fatty rats. PLoS One 11 (2016), 1–15.
79. [80] Girgih, A., Alashi, A., He, R., Malomo, S., Raj, P., et al. A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats. Nutrients 6 (2014), 5652–5666.
80. [81] Madani, Z., Sener, A., Malaisse, W.J., Dalila, A.Y., Sardine protein diet increases plasma glucagon-like peptide-1 levels and prevents tissue oxidative stress in rats fed a high-fructose diet. Mol. Med. Rep. 12 (2015), 7017–7026.
81. [82] Nazeer, R.A., Sampath, N.S., Jai Ganesh, R., In vitro and in vivo studies on the antioxidant activity of fish peptide isolated from the croaker (Otolithes ruber) muscle protein hydrolysate. Peptides 35 (2012), 261–268.
82. [83] Nobile, V., Duclos, E., Michelotti, A., Bizzaro, G., Negro, M., Soisson, F., Supplementation with a fish protein hydrolysate (Micromesistius poutassou): effects on body weight body composition, and CCK/GLP-1 secretion. Food Nutr Res. 60 (2016), 1–9.
83. [84] Cope, M., Allison, D.B., Weight loss and high protein diets: can soy help fight obesity?. Soy Connect. 12 (2004), 1–7.
84. [85] Marcone, S., Belton, O., Fitzgerald, D.J., Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis. Br. J. Clin. Pharmacol., 2016.
85. [86] Fujita, T., Soya proteins, water-soluble fibers and gelatins, basic aminoacids, and/or basic peptides as compositions for prevention of obesity. Japanese Kokai Tokkyo Koho, 2002.
86. [87] Miura, H., Nonsugar beverages and diet compositions containing soybean protein hydrolysates. Japanese Kokai Tokkyo Koho, 2002.
87. [88] Inaba, H., Sakai, K., Ota, A., Body fatdecreasing agents containing peptides and glutamine, and food compositions containing them. Japanese Kokai Tokkyo Koho, 2002.
88. [89] Zhang, X.Z., Wang, H.Y., Fu, X.Q., Wu, X.X., Xu, G.L., Bioactive small peptides from soybean protein. ‎Ann. N. Y. Acad Sci. 864 (2008), 640–645.
89. [90] Nakamori, T., Antiobesity effects of soy proteins and soy peptides. Food Style 21 (2002), 86–88.
90. [91] Nishi, T., Hara, H., Asano, K., Tomita, F., The soybean beta-conglycinin beta 51- 63 fragment suppresses appetite by stimulating cholecystokinin release in rats. J. Nutr. 8 (2003), 2537–2542.
91. [92] Nishi, T., Hara, H., Tomita, F., Soybean beta-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats. J. Nutr. 133 (2003), 352–357.
92. [93] Arroume, N., Froidevaux, R., Kapel, R., Cudennec, B., Ravallec, R., et al. Food peptides: purification: identification and role in the metabolism. Curr. Opin. Food Sci. 7 (2016), 101–107.
93. [94] Gu, Y., Wu, J., The potential of antioxidative and anti-inflammatory peptides in reducing the risk of cardiovascular diseases. Curr. Opin. Food Sci. 8 (2016), 25–32.
94. [95] Mulero, J., Zafrilla, P., Martםnez, A., Leal, M., Abellan, J., Pיptidos bioactivos. Clin. Invest. Arterioscler. 23 (2011), 219–227.
95. [96] Hirota, T., Nonaka, A., Matsushita, A., et al. Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings. Heart Vessels 26 (2011), 549–556.
96. [97] Aihara, K., Ishii, H., Yoshida, M., Casein-derived tripeptide Val-Pro–Pro (VPP), modulates monocyte adhesion to vascular endothelium. J. Atheroscler. Thromb. 16 (2009), 594–603.
97. [98] Nielsen, D.S., Theil, P.K., Larsen, L.B., Purup, S., Effect of milk hydrolysates on inflammation markers and drug-induced transcriptional alterations in cell-based models. J. Anim. Sci. 90 (2012), 403–405.
98. [99] Anandarajagopal, K., Anbu, J., Ajaykumar, T., Ananth, R., Kamal, S., In vitro antiinflamatory evaluation of Crude Bombax ceiba Extracts. Int. J. Pharm. Res. 3 (2012), 24–26.
99. [100] Gupta, V., Chauhan, S., Prakash, A., Mathur, A., Evaluation of in vitro and in vivo antiinflamatory activities of Parthenium camphora. Recent Res. Sci. Technol. 5 (2013), 33–39.
100. [101] Sakat, S., Juvekar, A., Gambhire, M., In vitro antioxidant and anti-inflammatory activity of methanol extract of Oxalis corniculatalinn. Int. J. Pharm. Pharm. Sci. 2 (2009), 146–155.
101. [102] Nacoulma, A., Compaoré, M., Lorenzi, M., Kiendrebeogo, M., In vitro antioxidant and anti-inflammatory activities of extracts from nicotiana tabacum L. (Solanaceae) leafy galls induced by rhodococcus fascians. J. Phytopathol. 160 (2012), 617–621.
102. [103] Lee, M., Kovacs-Nolan, J., Archbold, T., Fan, M., Juneja, L., et al. Therapeutic potential of hen egg white peptides for the treatment of intestinal inflammation. J. Funct. Foods 1 (2009), 161–169.
103. [104] Lau, F., Joseph, J., McDonald, J., Kalt, W., Attenuation of iNOS and COX2 by blueberry polyphenols is mediated through the suppression of NF-κB activation. J. Funct. Foods 1 (2009), 274–283.
104. [105] Pan, M., Yang, J., Tsai, M., Sang, S., Ch. Ho: anti-inflammatory effect of Momordica grosvenori Swingle extract through suppressed LPS-induced upregulation of iNOS and COX-2 in murine macrophages. J. Funct. Foods 1 (2009), 145–152.
105. [106] Xu, C., Yang, C., Yin, Y., Liu, J., Min, Y., Phosphopeptides (PPPs) from hen egg yolk phosvitin exert anti-inflammatory activity via modulation of cytokine expression. J. Funct. Foods 4 (2012), 718–726.
106. [107] Mejia, E.G., Dia, V.P., Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-??Bpathway in the macrophage. Peptides 30 (2009), 2388–2398.
107. [108] Bellamy, W., Takase, M., Yamauchi, K., Kawase, K., Shimamura, S., Tomita, M., Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121 (1992), 130–136.
108. [109] Clare, D., Swaisgood, H., Bioactive milk peptides: a prospectus. J. Dairy Sci. 83 (2000), 1187–1195.
109. [110] Vo, T., Ryu, B., Kim, S., Purification of novel anti-inflammatory peptides from enzymatic hydrolysate of the edible microalgal Spirulina maxima. J. Funct. Foods 5 (2013), 1336–1346.
110. [111] Chatterton, D.E., Nguyen, D.N., Bering, S.B., Sangild, P.T., Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int. J. Biochem. Cell Biol. 45:2013 (2013), 1730–1747.
111. [112] Nakamura, T., Hirota, T., Mizushima, K., et al. Milk-derived peptides, Val-Pro–Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein e-deficient mice: a preliminary study. J. Med. Food 16 (2013), 396–403.
112. [113] Mochizuki, M., Shigemura, H., Hasegawa, N., Antiinflammatory effect of enzymatic hydrolysate of corn gluten in an experimental model of colitis. J. Pharm. Pharmacol. 62:2010 (2010), 389–392.
113. [114] Wada, S., Sato, K., Ohta, R., et al. Ingestion of low dose pyroglutamyl leucine improves dextran sulfate sodium-induced colitis and intestinal microbiota in mice. ‎J. Agric. Food Chem. 61 (2013), 8807–8813.
114. [115] Boonloh, K., Kukongviriyapan, U., Pannangpetch, P., Kongyingyoes, B., Senggunprai, L., et al. Rice bran protein hydrolysates prevented interleukin-6- and high glucose-induced insulin resistance in hepg2 cells. Food Funct. 6 (2015), 566–573.
115. [116] Mohammad Shahi, M., Rashidi, M.-R., Mahboob, S., Haidari, F., Rashidi, B., Hanaee, J., Protective effect of soy protein on collagen-induced arthritis in rat. Rheumatol. Int. 32 (2012), 2407–2414.
116. [117] Nagarajan, S., Burris, R.L., Stewart, B.W., Wilkerson, J.E., Badger, T.M., Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J. Nutrition. 138 (2008), 332–337.
117. [118] Kovacs-Nolan, J., Zhang, H., Ibuki, M., et al. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochim. Biophys. Acta 1820 (2012), 1753–1763.
118. [119] Chia, C.F., Wang, B., Wang, Y.M., Zhang, B., Deng, S.G., Isolation and characterization of three antioxidant peptides from protein hydrolysate of bluefin leatherjacket (Navodon septentrionalis) heads. J. Funct. Foods 12 (2015), 1–10.
119. [120] Ahn, C.B., Je, J.Y., Cho, Y.S., Antioxidant and anti-inflammatory peptide fraction from salmon byproduct protein hydrolysates by peptic hydrolysis. Food Res. Int. 49 (2012), 92–98.
120. [121] Moronta, J., Smaldini, P.L., Docena, G.H., Añón, M.C., Peptides of amaranth were targeted as containing sequences with potential anti-inflammatory properties. J. Funct. Foods 21 (2016), 463–473.